Novel targets in head and neck cancer: Should we be optimistic?

Gabriel S. Krigsfeld, Christine H. Chung

Research output: Contribution to journalArticle

Abstract

Head and neck squamous cell carcinomas have distinct mutation and copy-number profiles depending on human papilloma-virus status. Although several challenges remain in biomarker implementation and clinical trial feasibility, incorporating available genomic data will expedite the development of novel therapeutics and predictive biomarker-driven clinical trials.

Original languageEnglish (US)
Pages (from-to)495-497
Number of pages3
JournalClinical Cancer Research
Volume21
Issue number3
DOIs
StatePublished - Feb 1 2015

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Novel targets in head and neck cancer: Should we be optimistic?'. Together they form a unique fingerprint.

  • Cite this